Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

187.15
Delayed Data
As of 4:00pm ET
 -10.63 / -5.37%
Today’s Change
184.50
Today|||52-Week Range
256.80
-10.89%
Year-to-Date
Harvey Investment Co Llc Buys Hexcel Corp, DowDuPont Inc, Duke Energy Corp, Sells All...
4:39pm / GuruFocus News - Paid Partner Content
Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall
Oct 17 / Zacks.com - Paid Partner Content
Allergan Shares Are Ready for a 30% Bounce Within Days
2:35pm / TheStreet.com - Paid Partner Content
Should You Listen to a Talking Head?
Oct 17 / TheStreet.com - Paid Partner Content
Recommended Allergan Reading
7:24am / TheStreet.com - Paid Partner Content
Sumitomo Life Insurance Co Buys DowDuPont Inc, BB&T Corp, Synopsys Inc, Sells Time Wa...
Oct 17 / GuruFocus News - Paid Partner Content
Cramer: Getting Out the Bad News Gives a Post-Earnings Boost
Oct 17 / TheStreet.com - Paid Partner Content
The Evolution of GM: Cramer's Top Takeaways
Oct 16 / TheStreet.com - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
Oct 17 / Zacks.com - Paid Partner Content
'Trump Stock' Cintas: Cramer's Top Takeaways
Oct 16 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close197.78
Today’s open195.73
Day’s range185.75 - 197.33
Volume13,755,144
Average volume (3 months)2,323,771
Market cap$66.1B
Dividend yield1.50%
Data as of 4:00pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.93%
Earnings growth (next 5 years)+11.83%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.93

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.13-0.37%
ABTAbbott Laboratories+0.71+1.29%
LLYEli Lilly and Co-0.33-0.38%
NVONovo Nordisk+0.82+1.66%
Data as of 4:02pm ET, 10/18/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.06
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts